Our recent research also found that CMKLR1 deficiency reduces mortality, improves the cognitive deficits of AD mice, and attenuates tau hyperphosphorylation in the brains of AD mice in vivo and in neuronal cells in vitro. The gene discussed is MAPT; the disease is Alzheimer disease.